In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Series B brings in $12.5mm for Molecular Biometrics

Executive Summary

Molecular Biometrics (diagnostics for cardiovascular, gynecological, and neurological use) has raised $12.5mm through its Series B venture round. New backer Atlas Venture led and was joined by current shareholders Safeguard Scientifics and Oxford Bioscience Partners. Funds will be used to complete an ongoing FDA clinical study of and launch its ViaMetrics-E, a noninvasive procedure to help identify viable embryos and potentially improve the success rate of in vitro fertilization.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register